Skip to main content
. 2020 Nov 12;10:19686. doi: 10.1038/s41598-020-76698-8

Figure 1.

Figure 1

Short-term EMPA treatment leads to a changed glucose metabolism (a) Fasting glucose and (b) oral glucose tolerance test (oGTT) after a 4 h fast with 1 g glucose/ kg body weight (n = 8–10). (c) AUC of oral glucose tolerance test. (d) Fasting insulin and (e) intraperitoneal (i.p.) insulin tolerance test (ipITT) after a 4 h fast with 1U insulin/kg body weight (n = 8–9). (f) AUC of intraperitoneal insulin tolerance test. (g) Fasting beta hydroxy butyrate (BHB) levels (n = 9–10). Data are expressed as means ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001, n.s. = not significant. WD, Western type diet only; EMPA, Western type diet enriched with empagliflozin.